Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome
about
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentConstipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.Rectal tone and compliance affected in patients with fecal incontinence after fistulotomyTong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance PAdvancing treatment options for chronic idiopathic constipation.Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.Comparison of pyridostigmine and bisacodyl in the treatment of refractory chronic constipation.Management Strategies for Abdominal Bloating and Distension.A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.Elobixibat for the treatment of constipation.Emerging treatments for chronic constipation.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.The use of non-narcotic pain medication in pediatric gastroenterology.Management of constipation in Parkinson's disease.New Options in Constipation Management.Targeting Small Bowel Receptors to Treat Constipation and Diarrhea.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Open channels for functional bowel disorders: guanylate cyclase C agonists in IBS and CC.Rectal hyposensitivity for non-noxious stimuli, postprandial hypersensitivity and its correlation with symptoms in complete spinal cord injury with neurogenic bowel dysfunction.Recent advances in understanding and managing chronic constipation
P2860
Q26751193-739D1D9D-0209-4A45-B0EE-6FA5F3668692Q33958710-C31C8B00-C2E8-4BA8-B87D-C1CB9A7A9889Q34254749-EC23C786-8744-4D9B-865D-890C28FAAA09Q34323319-C9F1E50F-A72B-47FF-A571-11E6983F8B18Q35270454-B8FBB7A7-48FB-43BC-90BC-932784DED07FQ35472905-ECF3C59A-F6A6-4325-B4FE-DE6BF41E93ECQ35858864-45FC22B2-F2B4-4695-A713-1686FD4A6077Q36426025-0EE774F8-8998-405D-83A0-77A4D485F736Q36599730-D1CB6EC0-8325-44B2-B1A2-1DFB6BE4504BQ37190545-DDF3779C-677B-48B6-B3BF-CD642891C163Q37585280-200B49F2-7B63-4419-95F6-CC62E0D58CDBQ37704523-FA323433-2BD2-4E0E-97D1-7657E9001F42Q38065210-BC7E83B8-0BB2-4DF0-8F43-83598FB4528FQ38129960-EB401A75-EB2B-4B69-9D88-FA1A17A66E48Q38175457-56CE9148-A164-46C2-AA87-114C7CB5F420Q38221358-4A3ADABA-F9B0-4FF2-B0B7-B05F5F15F946Q38300388-569BD3E9-467E-485E-A474-E766E704B817Q38602701-A5A666B3-116F-4677-959E-6710B27DAD35Q38673439-7E5EECF9-5D0D-46E6-BB10-17004D2E62B0Q42695148-1A238D1C-35CF-4BCC-9CC9-A09FC3522376Q43360555-649A3A0F-91BF-4C9A-8F19-C5E5C858C8EFQ50916416-A2180B84-4C79-4EBC-B92C-511BD102A77DQ58562464-AA53BDF1-14E9-4FD6-A56E-FB36347E1BEC
P2860
Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lubiprostone does not influenc ...... with irritable bowel syndrome
@ast
Lubiprostone does not influenc ...... with irritable bowel syndrome
@en
type
label
Lubiprostone does not influenc ...... with irritable bowel syndrome
@ast
Lubiprostone does not influenc ...... with irritable bowel syndrome
@en
prefLabel
Lubiprostone does not influenc ...... with irritable bowel syndrome
@ast
Lubiprostone does not influenc ...... with irritable bowel syndrome
@en
P2093
P2860
P1476
Lubiprostone does not influenc ...... with irritable bowel syndrome
@en
P2093
L Gangarosa
O S Palsson
W E Whitehead
P2860
P304
P356
10.1111/J.1365-2982.2011.01776.X
P577
2011-10-01T00:00:00Z